- You are here:
-
Home
- News
News
- Details
- Category: POZ.com
The global supply of tenofovir and six other important generic drugs must be ensured, warns a UNAIDS analysis.
- Details
- Category: POZ.com
The new global pandemic could also lead to greater susceptibility to HIV transmission.
- Details
- Category: POZ.com
A 2018 report had suggested that HIV-positive women’s use of the drug at conception increased the rate of the rare birth defects.
- Details
- Category: POZ.com
Researchers project the Brazilian man could become the first person deemed cured of HIV without a bone marrow transplant.
- Details
- Category: POZ.com
The placebo-controlled trial compared injections of cabotegravir given every eight weeks versus daily Truvada as PrEP.
- Details
- Category: POZ.com
The placebo-controlled trial compared injections of cabotegravir given every eight weeks versus daily Truvada as PrEP.
- Details
- Category: POZ.com
Disruptions in access to antiretroviral treatment due to the COVID-19 pandemic could lead to a major setback in combating HIV.
- Details
- Category: POZ.com
Plus: Their stigma-busting initiative gets a shout-out from POZ’s Best Celebrity Advocate 2019.
- Details
- Category: POZ.com
Antiretrovirals likely drive up rates, both directly and by helping people live long enough to develop high blood pressure.
- Details
- Category: POZ.com
The federal government can require foreign affiliates of U.S. companies to denounce sex work in order to secure HIV funding.
Subcategories
Fundraisers Article Count: 2
Health Article Count: 4
HIV / AIDS Article Count: 4
Partners Article Count: 285
POZ.com Article Count: 284
POZ Stories Article Count: 11
Page 7 of 25
- You are here:
-
Home
- News